Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003101-53Phase 4Completed
Phase 4, randomised trial in cardiometabolic risk (CMR) and Hypoandrogenism (TD) comparing Testosterone gel with Placebo (2 arms). Primary endpoint: Insulin sensitivity by QUICKI. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003101-53.